HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eeva Moilanen Selected Research

pinosylvin

5/2021Pinosylvin Shifts Macrophage Polarization to Support Resolution of Inflammation.
12/2018IL-6 in Osteoarthritis: Effects of Pine Stilbenoids.
1/2018Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
3/2016Pinosylvin Inhibits TRPA1-Induced Calcium Influx In Vitro and TRPA1-Mediated Acute Paw Inflammation In Vivo.
4/2015Pinosylvin and monomethylpinosylvin, constituents of an extract from the knot of Pinus sylvestris, reduce inflammatory gene expression and inflammatory responses in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eeva Moilanen Research Topics

Disease

74Inflammation (Inflammations)
03/2022 - 08/2005
22Asthma (Bronchial Asthma)
01/2022 - 08/2002
14Osteoarthritis
08/2021 - 01/2009
13Rheumatoid Arthritis
12/2021 - 01/2008
12Obesity
12/2021 - 01/2009
10Arthritis (Polyarthritis)
12/2021 - 06/2008
8Edema (Dropsy)
07/2021 - 09/2011
7Chronic Obstructive Pulmonary Disease (COPD)
12/2017 - 06/2008
6Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021 - 12/2013
6Pain (Aches)
10/2021 - 01/2008
6Lung Diseases (Lung Disease)
10/2021 - 01/2008
6Breast Neoplasms (Breast Cancer)
02/2020 - 12/2017
5Insulin Resistance
12/2021 - 01/2011
5Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 01/2018
5Fibrosis (Cirrhosis)
12/2018 - 07/2007
5Pneumonia (Pneumonitis)
09/2017 - 12/2008
5Necrosis
01/2017 - 08/2005
5Eosinophilia
06/2009 - 08/2005
5Atopic Dermatitis (Atopic Eczema)
08/2008 - 04/2003
4Schizophrenia (Dementia Praecox)
12/2021 - 08/2014
4Neurogenic Inflammation
03/2021 - 11/2016
3Alcoholism (Alcohol Abuse)
01/2022 - 01/2018
3Body Weight (Weight, Body)
12/2021 - 10/2012
3Cough
10/2021 - 04/2012
3Hypoxia (Hypoxemia)
01/2019 - 10/2015
3Neoplasms (Cancer)
01/2019 - 07/2009
3Asbestosis
01/2017 - 07/2007
3Hypersensitivity (Allergy)
11/2016 - 04/2012
3Renal Insufficiency (Renal Failure)
01/2014 - 12/2003
3Allergic Rhinitis
01/2009 - 04/2003
2Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 09/2009
2Joint Diseases (Joint Disease)
12/2021 - 03/2014
2Weight Gain
12/2021 - 12/2016
2Overweight
12/2021 - 08/2014
2Cardiotoxicity
02/2020 - 12/2017

Drug/Important Bio-Agent (IBA)

27Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2020 - 02/2002
25CytokinesIBA
08/2021 - 04/2003
22AdipokinesIBA
12/2021 - 01/2009
22Interleukin-6 (Interleukin 6)IBA
07/2021 - 07/2007
21Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2002
14LeptinIBA
12/2021 - 01/2009
14Pharmaceutical PreparationsIBA
03/2021 - 08/2005
12Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2019 - 07/2002
12CarrageenanIBA
01/2018 - 09/2011
11GlucocorticoidsIBA
03/2021 - 08/2002
10AdiponectinIBA
12/2021 - 01/2011
8Interleukin-8 (Interleukin 8)IBA
07/2021 - 12/2008
7ResistinIBA
12/2021 - 05/2011
7Ion Channels (Ion Channel)IBA
10/2021 - 01/2014
7Matrix Metalloproteinases (MMPs)IBA
04/2020 - 01/2011
7Complement Factor D (Factor D)IBA
02/2018 - 10/2012
6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 10/2004
6Dinoprostone (PGE2)FDA Link
01/2020 - 05/2006
6Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2009
5pinosylvinIBA
05/2021 - 04/2015
5AnkyrinsIBA
03/2021 - 01/2015
5C-Reactive ProteinIBA
12/2019 - 07/2007
5Immunoglobulin E (IgE)IBA
01/2018 - 08/2008
5AsbestosIBA
09/2017 - 07/2007
4Clozapine (Clozaril)FDA LinkGeneric
12/2021 - 08/2014
48-epi-prostaglandin F2alphaIBA
07/2021 - 07/2007
4Dexamethasone (Maxidex)FDA LinkGeneric
03/2021 - 04/2013
4LipidsIBA
11/2020 - 12/2013
4InterleukinsIBA
01/2019 - 01/2018
4Glycoproteins (Glycoprotein)IBA
01/2019 - 01/2017
4Prostaglandin-E SynthasesIBA
12/2017 - 09/2011
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2017 - 01/2008
3Glucose (Dextrose)FDA LinkGeneric
10/2021 - 10/2012
3Interleukin-4 (Interleukin 4)IBA
08/2021 - 12/2018
3Ibuprofen (Motrin)FDA LinkGeneric
01/2021 - 01/2009
3CollagenIBA
11/2020 - 01/2017
3ProstaglandinsIBA
01/2020 - 05/2012
3ChitinasesIBA
01/2019 - 01/2017
3EnzymesIBA
12/2017 - 09/2011
3Gold Sodium Thiomalate (Sodium Aurothiomalate)IBA
01/2017 - 06/2008
3Infliximab (Remicade)FDA Link
01/2017 - 11/2010
3CalciumIBA
03/2016 - 12/2003
3Leukotriene B4IBA
07/2015 - 07/2007
3N(6)-(1-iminoethyl)lysineIBA
04/2015 - 01/2013
3Antirheumatic Agents (DMARD)IBA
01/2015 - 06/2010
3AntioxidantsIBA
09/2009 - 07/2009
2Phosphotransferases (Kinase)IBA
03/2022 - 01/2014
2Mitogen-Activated Protein KinasesIBA
03/2022 - 01/2011
2Urokinase Plasminogen Activator ReceptorsIBA
01/2022 - 01/2017
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2022 - 08/2014
2Nicotinamide PhosphoribosyltransferaseIBA
12/2021 - 01/2014
2Antipsychotic Agents (Antipsychotics)IBA
12/2021 - 08/2014
2RNA (Ribonucleic Acid)IBA
01/2021 - 11/2020
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 01/2019
2Transforming Growth Factor beta (TGF-beta)IBA
08/2019 - 01/2019
2Bevacizumab (Avastin)FDA Link
07/2019 - 01/2019
2OvalbuminIBA
01/2019 - 10/2007
2StilbenesIBA
12/2018 - 01/2018
2nortrachelogeninIBA
12/2018 - 04/2017
2MetalsIBA
07/2018 - 01/2016

Therapy/Procedure

6Therapeutics
02/2020 - 10/2004
4Ligation
10/2015 - 06/2006
3Drug Therapy (Chemotherapy)
10/2021 - 10/2018
3Adjuvant Radiotherapy
02/2020 - 10/2018
2Combination Drug Therapy (Combination Chemotherapy)
07/2019 - 08/2009